A continuous peripheral nerve block catheter (CPNBC) is placed with its tip near to a target nerve/plexus, via which local anaesthetic is delivered. Nerve blocks for hand surgery typically last 6-8 hours, whereas nerve blocks for pain relief following total knee replacement can last 12-24 hours.
Increasing incidence of trauma and accidental injuries is expected to propel growth of the global continuous peripheral nerve block catheter market over the forecast period. For instance, according to January 2018 factsheet, 20–30% of older people who fall suffer moderate to severe injuries such as bruises, hip fractures, or head trauma, in the U.S.
Furthermore, numerous launches and approvals of new carrier screening tests are expected to drive carrier screening market growth throughout the forecast period. Invitae Corporation, for example, announced the debut of the Invitae Carrier Screen in June 2018, which is a test developed for better risk assessment to detect the possibility of the kid having a genetic condition.
Because of product approvals and the launch of novel carrier screening tests in the area, North America accounted for the greatest market share in 2018. For example, in October 2019, Sema4 announced the release of the Expanded Carrier Screen, a test that determines the chance of a kid developing an inherited genetic condition.
Moreover, lack of standard usage guidelines and trained personnel is also expected to aid in growth of the market. Usage of continuous peripheral nerve block catheter is not uniform and proper documentation for usage and proper guidance for local anesthesia and analgesics intake is not widely available. Placement of CPNBC requires high monitoring under the guidance of skilled professionals.
No comments:
Post a Comment